欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/3989/001
药品名称Everolimus Krka 2.5 mg tablets
活性成分
    • Everolimus 2.5 mg
剂型Tablet
上市许可持有人KRKA, d.d., Novo mesto Šmarješka cesta 6 Novo mesto 8501 Slovenia
参考成员国 - 产品名称Netherlands (NL)
Everolimus Krka 2,5 mg, tabletten
互认成员国 - 产品名称
    • Denmark (DK)
      Everolimus Krka
    • Belgium (BE)
      Everolimus Krka 2,5 mg tabletten/comprimés/Tabletten
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Austria (AT)
      Everolimus HCS 2,5 mg Tabletten
    • France (FR)
    • Portugal (PT)
    • Italy (IT)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Estonia (EE)
      EVEROLIMUS KRKA
    • Hungary (HU)
      EVEROLIMUS KRKA 2,5 mg tabletta
    • Bulgaria (BG)
      Everolimus KrkA
    • Czechia (CZ)
      Everolimus Krka
    • Romania (RO)
    • Slovakia (SK)
      Everolimus Krka 2,5 mg
    • Slovenia (SI)
      Everolimus Krka 2,5 mg tablete
    • Croatia (HR)
      Everolimus Krka 2,5 mg tablete
许可日期2018/05/30
最近更新日期2024/10/31
药物ATC编码
    • L01XE10 everolimus
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Multiple (Copy) Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase